Mannheimiosis in Animals
Introduction
Mannheimiosis is an acute bacterial respiratory disease primarily affecting ruminants, especially cattle and sheep. It is caused by Mannheimia haemolytica and is a major component of the bovine respiratory disease (BRD) complex, commonly referred to as “shipping fever.” The disease is characterized by severe pneumonia, high morbidity, and significant economic losses in livestock production.
Etiology
Causative Agent
The disease is caused by Mannheimia haemolytica, a Gram-negative, non-spore forming coccobacillus.
Characteristics
- Normal inhabitant of the upper respiratory tract
- Opportunistic pathogen activated by stress or immunosuppression
- Produces potent leukotoxin
Epidemiology
Species Affected
- Cattle (most significant)
- Sheep and goats
Transmission
- Aerosol spread from infected animals
- Proliferation of resident bacteria in stressed animals
Risk Factors
- Transportation stress
- Weaning
- Overcrowding
- Poor ventilation
- Concurrent viral infections (e.g., IBR, BRSV)
Pathogenesis
Mechanism of Disease
Under stress, Mannheimia haemolytica multiplies rapidly in the upper respiratory tract and descends into the lungs. The bacteria adhere to the respiratory epithelium and release virulence factors.
Role of Leukotoxin
- Destroys leukocytes (especially neutrophils)
- Triggers release of inflammatory mediators
- Leads to severe lung tissue damage
Disease Progression
- Rapid onset of fibrinous pneumonia
- Accumulation of exudate in alveoli
- Impaired gas exchange
Clinical Signs
Early Signs
- Fever
- Depression
- Reduced feed intake
Respiratory Signs
- Rapid, shallow breathing
- Coughing
- Nasal discharge (may be mucopurulent)
- Dyspnea
Advanced Signs
- Severe respiratory distress
- Open-mouth breathing
- Cyanosis
- Death in severe cases
Summary for Practitioners
Mannheimiosis should be suspected in recently transported or stressed cattle showing acute respiratory signs and fever. Early intervention is critical to reduce mortality and limit spread within the herd.
Postmortem Findings
Gross Lesions
- Fibrinous bronchopneumonia
- Consolidation of lung lobes (especially cranial lobes)
- Fibrin deposits on pleura (pleuritis)
- Fluid accumulation in thoracic cavity
Microscopic Lesions
- Necrosis of lung tissue
- Inflammatory cell infiltration
- Fibrin exudation
Diagnosis
Clinical Diagnosis
Based on respiratory signs, history of stress, and herd outbreaks.
Laboratory Diagnosis
- Bacterial culture from lung tissue or nasal swabs
- PCR for pathogen identification
- Antimicrobial sensitivity testing
Differential Diagnosis
- Other components of BRD complex (viral infections)
- Mycoplasma pneumonia
- Pasteurellosis
Summary for Practitioners
Confirm diagnosis with laboratory testing where possible, but treatment should not be delayed in acute outbreaks. Early antibiotic therapy is often life-saving.
Treatment
Antibiotic Therapy
- Macrolides (e.g., tulathromycin)
- Tetracyclines
- Florfenicol
Supportive Care
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Fluid therapy
- Improved environmental conditions
Summary for Practitioners
Prompt antimicrobial therapy combined with anti-inflammatory treatment improves survival. Group treatment may be necessary in herd outbreaks.
Control and Prevention
Management Practices
- Minimize stress during transport and handling
- Ensure proper ventilation and housing
- Implement good nutrition programs
Vaccination
- Vaccines targeting Mannheimia haemolytica are available
- Often used as part of BRD prevention programs
Biosecurity
- Quarantine new animals
- Monitor herd health closely
Summary for Practitioners
Prevention focuses on stress reduction, vaccination, and early detection. Preconditioning programs in cattle significantly reduce the risk of Mannheimiosis.
Zoonotic Importance
Mannheimiosis is not considered a zoonotic disease.
Economic Importance
The disease is a major contributor to economic losses in the cattle industry due to treatment costs, reduced weight gain, and mortality.
Summary
Mannheimiosis is a severe bacterial respiratory disease associated with stress and management factors. It is characterized by acute pneumonia and requires prompt treatment and preventive strategies to minimize its impact.
Home